These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27046703)

  • 1. Progress towards achieving global tuberculosis control: so near, yet so far.
    Zumla A; Davies PD
    Int J Tuberc Lung Dis; 2016 Mar; 20(3):285-6. PubMed ID: 27046703
    [No Abstract]   [Full Text] [Related]  

  • 2. Tuberculosis control goals unlikely to be met by 2005.
    Sharma DC
    Lancet; 2004 Apr; 363(9415):1122. PubMed ID: 15068013
    [No Abstract]   [Full Text] [Related]  

  • 3. The need for global action against multidrug-resistant tuberculosis.
    Heymann SJ; Brewer TF; Wilson ME; Fineberg HV
    JAMA; 1999 Jun; 281(22):2138-40. PubMed ID: 10367825
    [No Abstract]   [Full Text] [Related]  

  • 4. Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?
    Gupta R; Raviglione MC; Espinal MA
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1078-9. PubMed ID: 11769764
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease.
    Cohn DL; Bustreo F; Raviglione MC
    Clin Infect Dis; 1997 Jan; 24 Suppl 1():S121-30. PubMed ID: 8994791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public health. Responding to market failures in tuberculosis control.
    Gupta R; Kim JY; Espinal MA; Caudron JM; Pecoul B; Farmer PE; Raviglione MC
    Science; 2001 Aug; 293(5532):1049-51. PubMed ID: 11463877
    [No Abstract]   [Full Text] [Related]  

  • 7. Addressing the threat of tuberculosis caused by extensively drug-resistant Mycobacterium tuberculosis.
    Wkly Epidemiol Rec; 2006 Oct; 81(41):386-90. PubMed ID: 17042081
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiple drug resistance in tuberculosis.
    Reichman LB
    Chest; 1997 Sep; 112(3):855. PubMed ID: 9315829
    [No Abstract]   [Full Text] [Related]  

  • 9. Tuberculosis control poses global challenges.
    Traynor K
    Am J Health Syst Pharm; 2007 Aug; 64(16):1672-4. PubMed ID: 17687052
    [No Abstract]   [Full Text] [Related]  

  • 10. Control of tuberculosis in India.
    Mohapatra PR
    Lancet; 2003 Oct; 362(9391):1243. PubMed ID: 14568763
    [No Abstract]   [Full Text] [Related]  

  • 11. The worldwide epidemic of multidrug-resistant tuberculosis.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2011 May; 11(5):333. PubMed ID: 21530885
    [No Abstract]   [Full Text] [Related]  

  • 12. WHO's 2013 global report on tuberculosis: successes, threats, and opportunities.
    Zumla A; George A; Sharma V; Herbert N; Baroness Masham of Ilton
    Lancet; 2013 Nov; 382(9907):1765-7. PubMed ID: 24269294
    [No Abstract]   [Full Text] [Related]  

  • 13. Rational 'DOTS plus' for the control of MDR-TB.
    Espinal MA; Dye C; Raviglione M; Kochi A
    Int J Tuberc Lung Dis; 1999 Jul; 3(7):561-3. PubMed ID: 10423218
    [No Abstract]   [Full Text] [Related]  

  • 14. [Shortened, strictly supervised tuberculosis treatment in populations with moderate drug resistance levels: international impact perspective].
    Santos-Preciado JI; Franco-Paredes C
    Rev Invest Clin; 2005; 57(3):488-90. PubMed ID: 16187710
    [No Abstract]   [Full Text] [Related]  

  • 15. Stop TB Partnership has provided treatments for 10 million people in 6 years.
    Wkly Epidemiol Rec; 2007 Jun; 82(22/23):206-7. PubMed ID: 17542093
    [No Abstract]   [Full Text] [Related]  

  • 16. Progress towards TB reduction targets is faltering, report finds.
    Cousins S
    BMJ; 2017 Oct; 359():j4758. PubMed ID: 29030533
    [No Abstract]   [Full Text] [Related]  

  • 17. XDR tuberculosis--implications for global public health.
    Raviglione MC; Smith IM
    N Engl J Med; 2007 Feb; 356(7):656-9. PubMed ID: 17301295
    [No Abstract]   [Full Text] [Related]  

  • 18. Slow elimination of multidrug-resistant tuberculosis.
    Dye C; Williams BG
    Sci Transl Med; 2009 Oct; 1(3):3ra8. PubMed ID: 20368167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ending tuberculosis by 2030: can we do it?
    Suthar AB; Zachariah R; Harries AD
    Int J Tuberc Lung Dis; 2016 Sep; 20(9):1148-54. PubMed ID: 27510238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inadequacy of the current WHO re-treatment regimen in a central Siberian prison: treatment failure and MDR-TB.
    Kimerling ME; Kluge H; Vezhnina N; Iacovazzi T; Demeulenaere T; Portaels F; Matthys F
    Int J Tuberc Lung Dis; 1999 May; 3(5):451-3. PubMed ID: 10331736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.